Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Monte Rosa Therapeutics, Inc.(GLUE) | 3,180,780 | 3,180,780 | 0 | 52,324 | 76,975 | 47.34% | +24,651 |
| Century Therapeutics, Inc. | 12,166,109 | 12,166,109 | 0 | 27,495 | 29,807 | 18.33% | +2,312 |
| Contineum Therapeutics, Inc. | 542,628 | 542,628 | 0 | 7,087 | 8,894 | 5.47% | +1,807 |
| CRISPR Therapeutics AG(CRSP) | 148,831 | 148,831 | 0 | 7,080 | 8,117 | 4.99% | +1,037 |
| Jade Biosciences, Inc. | 1,525,820 | 991,783 | -534,037 | 21,438 | 22,037 | 13.55% | +600 |
| Skye Bioscience, Inc. | 2,007,704 | 2,007,704 | 0 | 1,234 | 1,392 | 0.86% | +158 |
| Tempest Therapeutics, Inc. | 269,772 | 269,772 | 0 | 442 | 299 | 0.18% | -143 |
| Lenz Therapeutics, Inc. | 2,656,888 | 2,656,888 | 0 | 24,311 | 15,091 | 9.28% | -9,219 |